Omnicell, Inc. - Common Stock - Nakit Akışı (NASDAQ:OMCL)

Financials

İşletme faaliyetlerinden elde edilen nakit 185.87 M231.81 M77.78 M181.09 M187.72 M127.3 M 155.88 M Yatırım faaliyetlerinden elde edilen nakit -279.87 M-412.5 M-58.67 M-55.02 M-52.79 M-60.36 M -60.49 M Finansman faaliyetlerinden elde edilen nakit 456.27 M47.36 M-20.95 M23.42 M-235.58 M-218.32 M -219.96 M Serbest nakit akışı 185.87 M231.81 M77.78 M181.09 M187.72 M86.89 M 114.2 M

Omnicell, Inc. - Common Stock

Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, CA. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.

OMCL

Financials

Omnicell, Inc. - Common Stock

Haberler

Omnicell (OMCL) Up 0.1% Since Last Earnings Report: Can It Continue?

Omnicell Stock Surges 57.3% in a Year: What's Driving It?

Should You Buy Omnicell (OMCL) After Golden Cross?

OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold?

How Much Upside is Left in Omnicell (OMCL)? Wall Street Analysts Think 39.87%

Omnicell, Inc. (OMCL) Shareholder/Analyst Call Prepared Remarks Transcript

Can Platform Expansion Support Hims & Hers Stock Before Q1 Earnings?

Here's Why Omnicell (OMCL) is a Strong Momentum Stock

DaVita Stock Up Following Q1 Earnings & Revenue Beat, Margins Expand

Omnicell (OMCL) is a Great Momentum Stock: Should You Buy?

Zacks Industry Outlook Highlights Veeva Systems, Doximity and Omnicell

3 Medical Info Systems Stocks Riding the GenAI Wave in a Tough Market